Begin with the end in mind: designing synthetic antibiotics with a universal mechanism of action

  07 May 2020

The rising threat of antimicrobial resistance (AMR) is prompting many researchers to investigate potential new antibiotics. Preventing the spread of dangerous bacteria, especially in a hospital environment, could save the lives of many patients who die from conditions such as sepsis.

Drug Target Review’s Victoria Rees spoke to James Graham, Executive Director of Recce Pharmaceuticals, to find out how researchers are attempting to combat harmful bacteria with a novel range of synthetic antibiotics.

Further reading: Drug Target Review
Author(s): Drug Target Review
Smart Innovations  
Back


Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market
  • Global reach for funding / co-development / licensing
Display your technology and make use of the Continuous AMR Partnering Initiative >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!